Skip Navigation LinksHome > August 1990 - Volume 73 - Issue 2 > Pharmacokinetics of Long-Term Propofol Infusion Used for Sed...

Pharmacokinetics of Long-Term Propofol Infusion Used for Sedation in ICU Patients.

Albanese, Jacques M.D.; Martin, Claude M.D.; Lacarelle, Bruno Ph.D.; Saux, Pierre M.D.; Durand, Alain Ph.D.; Gouin, Fran├žois M.D.

Collapse Box


The pharmacokinetics of propofol were determined in nine patients (seven men, two women, (mean +/- SD) 55.8 +/- 21.2 yr. 65.2 +/- 8 kg) requiring prolonged mechanical ventilation of their lungs. After an initial dose of 1-3 mg/kg, propofol was administered iv at 3 mg/kg/h for 72 h. Arterial blood samples were collected at selected times during and up to 72 h after infusion. Propofol whole blood concentrations were determined by high-performance liquid chromatography with fluorescence detection. Individual pharmacokinetic parameters were estimated by noncompartmental analysis. Derived pharmacokinetic parameters showed a long terminal phase (T1/2 = 1878 +/- 672 min), a large volume of distribution at steady state (Vd22 = 1666 +/- 756 I), and a high total body clearance (CI = 1.57 +/- 0.56 1/min). While the propofol terminal elimination half-life is longer than that previously reported, emergence from sedation after prolonged administration will be governed by both redistribution mechanisms arising from the large distribution volumes and elimination from the body.
(C) 1990 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.

Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.